|
FY2025
12 months to Oct 31, 2025
|
FY2024
12 months to Oct 31, 2024
|
FY2023
12 months to Oct 31, 2023
|
|
|---|---|---|---|
| Operating expenses: | |||
| Research and development | |||
| General and administrative | |||
| Total operating expenses | |||
| Loss from operations | |||
| Other (income) expense, net: | |||
| Change in fair value of convertible debentures embedded derivative liabilities | |||
| Change in fair value of warrant liabilities | |||
| Change in fair value of convertible debentures | |||
| Interest income | |||
| Interest expense | |||
| Loss on extinguishment of convertible debentures | |||
| Gain on extinguishment of debt | |||
| Other expenses (income), net | |||
| Total other income, net | |||
| Net loss before income taxes | |||
| Provision for (recovery of) income taxes | |||
| Net loss | |||
| Deemed dividend attributable to redeemable convertible preferred shareholders | |||
| Net loss attributable to common shareholders, basic | |||
| Other comprehensive loss: | |||
| Unrealized (gain) loss on available-for-sale investments | |||
| Total comprehensive loss | |||
| Net loss per share of common shares, basic | |||
| Net loss per share of common shares, diluted | |||
| Weighted-average common shares outstanding, basic | |||
| Weighted-average common shares outstanding, diluted |
Loading...